These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8667424)

  • 1. Mismatch repair genes matched to several new roles in cancer.
    Holzman D
    J Natl Cancer Inst; 1996 Jul; 88(14):950-1. PubMed ID: 8667424
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA repair: a double-edged sword.
    Wei Q; Frazier ML; Levin B
    J Natl Cancer Inst; 2000 Mar; 92(6):440-1. PubMed ID: 10716953
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impairment of DNA damage response and cancer].
    Rancoule C; Vallard A; Guy JB; Espenel S; Sauvaigo S; Rodriguez-Lafrasse C; Magné N
    Bull Cancer; 2017 Nov; 104(11):962-970. PubMed ID: 29132683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging cancer therapeutic opportunities target DNA-repair systems.
    Ding J; Miao ZH; Meng LH; Geng MY
    Trends Pharmacol Sci; 2006 Jun; 27(6):338-44. PubMed ID: 16697054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic drug resistance and DNA repair.
    Burt RK; Poirier MC; Link CJ; Bohr VA
    Ann Oncol; 1991 May; 2(5):325-34. PubMed ID: 1954176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining carefully selected drug, patient genetics may lead to total tumor death.
    Tuma RS
    J Natl Cancer Inst; 2007 Oct; 99(20):1505-6, 1509. PubMed ID: 17925530
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer, DNA repair mechanisms, and resistance to chemotherapy.
    Fojo T
    J Natl Cancer Inst; 2001 Oct; 93(19):1434-6. PubMed ID: 11584051
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
    Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
    Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA repair as a therapeutic target].
    Eberst L; Brahmi M; Cassier PA
    Bull Cancer; 2017 Nov; 104(11):988-998. PubMed ID: 29132681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic structures in DNA damage responses & cancer.
    Tainer JA
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):129-133. PubMed ID: 25934179
    [No Abstract]   [Full Text] [Related]  

  • 12. Epirubicin-induced oxidative DNA damage and evidence for its repair in lymphocytes of cancer patients who are undergoing chemotherapy.
    Olinski R; Jaruga P; Foksinski M; Bialkowski K; Tujakowski J
    Mol Pharmacol; 1997 Nov; 52(5):882-5. PubMed ID: 9351979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
    Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.
    Sandhu SK; Yap TA; de Bono JS
    Eur J Cancer; 2010 Jan; 46(1):9-20. PubMed ID: 19926276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the DNA mismatch repair genes in colorectal tumorigenesis.
    Boland CR
    Int J Cancer; 1996 Feb; 69(1):47-9. PubMed ID: 8600059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of DNA transcription- and repair-related genes in cisplatin-resistant human ovarian carcinoma cell line COC1/DDP].
    Cao MM; Zhang JR; Wang SM; Hu XG; Hu LJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1478-81. PubMed ID: 16354609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair: a reinvigorated therapeutic target.
    Bates SE
    Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities.
    Soll JM; Sobol RW; Mosammaparast N
    Trends Biochem Sci; 2017 Mar; 42(3):206-218. PubMed ID: 27816326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Potential Therapeutic Agents based on DNA Sequence- Selective Binding Substances.
    Sheh L; Waring MJ
    Curr Top Med Chem; 2015; 15(14):1291-2. PubMed ID: 25869486
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA repair pathways and their implication in cancer treatment.
    Pallis AG; Karamouzis MV
    Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.